PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review

Robert S. Brody(AstraZeneca (France)), Yiduo Zhang(AstraZeneca (United States)), Marc Ballas(AstraZeneca (United States)), Mohd Kashif Siddiqui(PAREXEL International (India)), Palvi Gupta(PAREXEL International (India)), Craig Barker(AstraZeneca (United Kingdom)), Anita Midha(AstraZeneca (United Kingdom)), Jill Walker(AstraZeneca (United Kingdom))
Lung Cancer
August 10, 2017
10.1016/j.lungcan.2017.08.005
Cited by 317Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis